🇺🇸 Atorvastatin Calcium Tablets in United States

218 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Myalgia — 33 reports (15.14%)
  2. Muscle Spasms — 29 reports (13.3%)
  3. Dysgeusia — 24 reports (11.01%)
  4. Nausea — 22 reports (10.09%)
  5. Pain In Extremity — 22 reports (10.09%)
  6. Dizziness — 20 reports (9.17%)
  7. Drug Ineffective — 18 reports (8.26%)
  8. Arthralgia — 17 reports (7.8%)
  9. Rash — 17 reports (7.8%)
  10. Diarrhoea — 16 reports (7.34%)

Source database →

Atorvastatin Calcium Tablets in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Atorvastatin Calcium Tablets approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Atorvastatin Calcium Tablets in United States?

NYU Langone Health is the originator. The local marketing authorisation holder may differ — check the official source linked above.